Mike Hubank
@generoom.bsky.social
Clinical Genomics in the UK.
Scientific Director of Clinical Genomics at the Royal Marsden and North Thames GLH. Prof of Translational Genomics at ICR, London
Scientific Director of Clinical Genomics at the Royal Marsden and North Thames GLH. Prof of Translational Genomics at ICR, London
July 11, 2025 at 1:19 PM
Wendy Bickmore closing #GenomeScience25 with a fascinating update on the latest thinking about how enhancers work in the #genome.
Perfect end to a great meeting 😃
Perfect end to a great meeting 😃
July 11, 2025 at 10:58 AM
Wendy Bickmore closing #GenomeScience25 with a fascinating update on the latest thinking about how enhancers work in the #genome.
Perfect end to a great meeting 😃
Perfect end to a great meeting 😃
Actually footage af the reviewer appreciating your dedication.
July 10, 2025 at 5:30 PM
Actually footage af the reviewer appreciating your dedication.
Great start to #GenomeScience25 with a fascinating history of Crick and then @minomatt.bsky.social describing the amazing application of #nanopore in brain tumor classification.
Now we have condensed updates from the tech companies.
Now we have condensed updates from the tech companies.
July 9, 2025 at 3:44 PM
Great start to #GenomeScience25 with a fascinating history of Crick and then @minomatt.bsky.social describing the amazing application of #nanopore in brain tumor classification.
Now we have condensed updates from the tech companies.
Now we have condensed updates from the tech companies.
We also have to overcome risk-averse data governance challenges, and take a system-wide view of health economics to allow savings made by #genomics to be fed back to support its implementation.
But the potential benefits are massive. I support the vision and will try hard to help deliver it.
But the potential benefits are massive. I support the vision and will try hard to help deliver it.
July 7, 2025 at 11:13 AM
We also have to overcome risk-averse data governance challenges, and take a system-wide view of health economics to allow savings made by #genomics to be fed back to support its implementation.
But the potential benefits are massive. I support the vision and will try hard to help deliver it.
But the potential benefits are massive. I support the vision and will try hard to help deliver it.
Not everything will deliver, and we need to reflect on priorities in an economically difficult climate. The #genomics itself is almost the easy part. To create the most clinical benefit, we will have to connect genomics with outcome data in national IT projects (to date, not our forte)
July 7, 2025 at 11:10 AM
Not everything will deliver, and we need to reflect on priorities in an economically difficult climate. The #genomics itself is almost the easy part. To create the most clinical benefit, we will have to connect genomics with outcome data in national IT projects (to date, not our forte)
Another productive and fun #genomics walk with my friend and path guru Stephen Fox from
@petermaccc.bsky.social
Genomics is just a bed of Roses 🌹
@petermaccc.bsky.social
Genomics is just a bed of Roses 🌹
June 3, 2025 at 6:30 PM
Another productive and fun #genomics walk with my friend and path guru Stephen Fox from
@petermaccc.bsky.social
Genomics is just a bed of Roses 🌹
@petermaccc.bsky.social
Genomics is just a bed of Roses 🌹
January 30, 2025 at 12:18 PM
January 29, 2025 at 3:37 PM
Angela Hamblin on how the Haemonc Rapid WGS network will speed up comprehensive WGS Dx for leukemia to < 7 days.
January 29, 2025 at 12:48 PM
Angela Hamblin on how the Haemonc Rapid WGS network will speed up comprehensive WGS Dx for leukemia to < 7 days.
Sandi Deans from #NHS England on expanding the use of SoC gene panel data to support #clinicaltrials
#FOG2025
#FOG2025
January 29, 2025 at 12:32 PM
Sandi Deans from #NHS England on expanding the use of SoC gene panel data to support #clinicaltrials
#FOG2025
#FOG2025
Barnaby Clark now on improving Molecular testing success rates for neurological cancers with RNALater.
January 29, 2025 at 12:17 PM
Barnaby Clark now on improving Molecular testing success rates for neurological cancers with RNALater.
Emma Baple on the very high genomic Dx rate - 71% - in renal cystic disease
January 29, 2025 at 12:04 PM
Emma Baple on the very high genomic Dx rate - 71% - in renal cystic disease
Sally George wraps up a fantastic launch meeting of SMP2- Stratified Medicine Pediatrics 2- with a summary of the successes of SMP1.
Focus on characterising relapsed #Pediatriccancer. Supported by #CRUK #genomics #ctDNA
An exciting next 5 years in prospect!
Focus on characterising relapsed #Pediatriccancer. Supported by #CRUK #genomics #ctDNA
An exciting next 5 years in prospect!
November 22, 2024 at 3:19 PM
Sally George wraps up a fantastic launch meeting of SMP2- Stratified Medicine Pediatrics 2- with a summary of the successes of SMP1.
Focus on characterising relapsed #Pediatriccancer. Supported by #CRUK #genomics #ctDNA
An exciting next 5 years in prospect!
Focus on characterising relapsed #Pediatriccancer. Supported by #CRUK #genomics #ctDNA
An exciting next 5 years in prospect!